dokumendiregister.ee
Sissetulev kiriAvalik

Euroopa farmakopöa monograafia asjus

Ravimiamet · 14. mai 2025
Viit
REP-1/2475-1
Registreeritud
14. mai 2025
Dokumendi liik
Sissetulev kiri
Adressaat
European Directorate for the Quality of Medicines & HealthCare
Saabumis/saatmisviis
e-post
Funktsioon
REP Euroopa Farmakopöaga seotud asjaajamine
Sari
REP-1 Euroopa Farmakopöa alane kirjavahetus
Toimik
REP-1/2025
Vastutaja
Signe Leito (RA, Peadirektori asetäitja valdkond, Labor)

Failid

Sisu (failidest)

Signe Leito Saatja: [email protected] Saatmisaeg: kolmapäev, 14. mai 2025 17:00 Adressaat: Signe Leito Teema: Survey for information on approved products containing difloxacin hydrochloride trihydrate for veterinary use - Group 10A: EDQM-2025-02040-mail Tähelepanu! Tegemist on väljastpoolt asutust saabunud kirjaga. Tundmatu saatja korral palume linke ja faile mitte avada. Please make sure to include in any reply our mail reference: EDQM-2025-02040-mail **************************************************************************** European Pharmacopoeia Commission Secretariat RZ/PH/ 2025-02041L Strasbourg, 14 May 2025 JSB/mk LETTER FOR THE ATTENTION OF NPAs Copy: Presidium Dear Colleagues, Please find below the link to an enquiry for information on approved products containing difloxacin hydrochloride trihydrate for veterinary use (2239), as well as other forms of difloxacin. https://survey.edqm.eu/index.php?r=survey/index&sid=157693&lang=en In order to have access to the enquiry, please copy and paste the link into your Internet browser. Deadline for replies: 3 June 2025. 1 Best regards, On behalf of Dr Jaume Sanz-Biset Mireille Kopf Secretarial Assistant European Pharmacopoeia Department EDQM - Council of Europe Tel.: +33 (0)3 88 41 28 53 / Fax: +33 (0)3 88 41 27 71 **************************************************************************** Please make sure to include in any reply our mail reference: EDQM-2025-02040-mail 2
Allikas: Ravimiamet dokumendiregister →